Seeking Alpha

Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment ...

WATERTOWN, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics ...
Yahoo Finance

Werewolf Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment ...

WATERTOWN, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of ...
Seeking Alpha

Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global ...

WATERTOWN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics ...
Yahoo Finance

Werewolf Therapeutics to Present at H. C. Wainwright Global Investment Conference

CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated ...